ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,000Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 162

$899K Total Retail Price of All Prescriptions

Rank: 28 out of 162

606 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 606 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

10% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 2,548 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$128 was the average price of a prescription from this provider, compared to $228 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVETIRACETAM 676 179 1 3
LAMOTRIGINE 579 161 2 8
GABAPENTIN 417 153 3 1
PHENYTOIN SODIUM EXTENDED 414 134 10 4 13
CARBIDOPA-LEVODOPA 373 306 5 2
HYDROCODONE-ACETAMINOPHEN 370 72 S3 6 7
TOPIRAMATE 299 63 7 6
CARBAMAZEPINE 189 22 8 16
DILANTIN 174 81 9 23
DIVALPROEX SODIUM ER 171 53 10 20
DONEPEZIL HCL 136 103 11 4
LYRICA 131 34 12 11
DIVALPROEX SODIUM 121 21 13 22
PRIMIDONE 116 33 14 9
NAMENDA 112 73 15 5
ROPINIROLE HCL 105 90 16 10
PROPRANOLOL HCL 92 47 17 33
PRAMIPEXOLE DIHYDROCHLORIDE 83 73 18 18
BACLOFEN 82 0 19 12
TRAMADOL HCL 81 0 20 35
CITALOPRAM HBR 72 37 21 21
TIZANIDINE HCL 72 35 21 19
OXCARBAZEPINE 71 13 23 25
VALPROIC ACID 68 0 24 96
VIMPAT 66 0 25 14
CLOPIDOGREL 64 50 26 38
LAMICTAL 63 0 27 51
PROMETHAZINE HCL 59 0 R 28 47
KEPPRA 53 0 29 50
PLAVIX 52 39 30 49
OXYCODONE-ACETAMINOPHEN 50 0 S2 31 95
SUMATRIPTAN SUCCINATE 50 0 31 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.